H. Farber and J. Loscalzo, Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.351, issue.16, pp.1655-1665, 2004.
DOI : 10.1056/NEJMra035488

J. Newman, R. Trembath, J. Morse, E. Grunig, J. Loyd et al., Genetic basis of pulmonary arterial hypertension, Journal of the American College of Cardiology, vol.43, issue.12, pp.33-39, 2004.
DOI : 10.1016/j.jacc.2004.02.028

R. Machado, M. Aldred, V. James, R. Harrison, B. Patel et al., Mutations of the TGF-?? type II receptorBMPR2 in pulmonary arterial hypertension, Human Mutation, vol.315, issue.2, pp.121-132, 2006.
DOI : 10.1002/humu.20285

F. Liu, F. Ventura, J. Doody, and J. Massague, Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs., Molecular and Cellular Biology, vol.15, issue.7, pp.3479-3486, 1995.
DOI : 10.1128/MCB.15.7.3479

R. Moore, F. Otsuka, and S. Shimasaki, Molecular Basis of Bone Morphogenetic Protein-15 Signaling in Granulosa Cells, Journal of Biological Chemistry, vol.278, issue.1, pp.304-310, 2003.
DOI : 10.1074/jbc.M207362200

M. Ono, Y. Sawa, S. Mizuno, N. Fukushima, H. Ichikawa et al., Hepatocyte Growth Factor Suppresses Vascular Medial Hyperplasia and Matrix Accumulation in Advanced Pulmonary Hypertension of Rats, Circulation, vol.110, issue.18, pp.2896-2902, 2004.
DOI : 10.1161/01.CIR.0000146342.30470.30

B. Sztrymf, F. Coulet, B. Girerd, A. Yaici, X. Jais et al., Mutation, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.12, pp.1377-1383, 2008.
DOI : 10.1164/rccm.200712-1807OC
URL : https://hal.archives-ouvertes.fr/inserm-00668454

S. Eddahibi, C. Guignabert, A. Barlier-mur, L. Dewachter, E. Fadel et al., Cross Talk Between Endothelial and Smooth Muscle Cells in Pulmonary Hypertension: Critical Role for Serotonin-Induced Smooth Muscle Hyperplasia, Circulation, vol.113, issue.15, pp.1857-1864, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.591321

E. Marcos, E. Fadel, O. Sanchez, M. Humbert, P. Dartevelle et al., Serotonin-Induced Smooth Muscle Hyperplasia in Various Forms of Human Pulmonary Hypertension, Circulation Research, vol.94, issue.9, pp.1263-1270, 2004.
DOI : 10.1161/01.RES.0000126847.27660.69

Z. Deng, J. Morse, S. Slager, N. Cuervo, K. Moore et al., Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor???II Gene, The American Journal of Human Genetics, vol.67, issue.3, pp.737-744, 2000.
DOI : 10.1086/303059

K. Lane, R. Machado, M. Pauciulo, J. Thomson, J. Phillips et al., Heterozygous germline mutations in BMPR2, encoding a TGFbeta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium, Nat Genet, vol.26, pp.81-84, 2000.

S. Eddahibi, M. Humbert, E. Fadel, B. Raffestin, M. Darmon et al., Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension, Journal of Clinical Investigation, vol.108, issue.8
DOI : 10.1172/JCI200112805

L. Dewachter, S. Adnot, E. Fadel, M. Humbert, B. Maitre et al., Angiopoietin/Tie2 Pathway Influences Smooth Muscle Hyperplasia in Idiopathic Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.174, issue.9, pp.1025-1033, 2006.
DOI : 10.1164/rccm.200602-304OC

P. Hewett and J. Murray, Immunomagnetic purification of human microvessel endothelial cells using Dynabeads coated with monoclonal antibodies to PECAM

P. Chomczynski and N. Sacchi, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Analytical Biochemistry, vol.162, issue.1, pp.156-159, 1987.
DOI : 10.1016/0003-2697(87)90021-2

M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Analytical Biochemistry, vol.72, issue.1-2, pp.248-254, 1976.
DOI : 10.1016/0003-2697(76)90527-3

N. Morrell, X. Yang, P. Upton, K. Jourdan, N. Morgan et al., Altered Growth Responses of Pulmonary Artery Smooth Muscle Cells From Patients With Primary Pulmonary Hypertension to Transforming Growth Factor-??1 and Bone Morphogenetic Proteins, Circulation, vol.104, issue.7, pp.790-795, 2001.
DOI : 10.1161/hc3201.094152

A. Sobolewski, N. Rudarakanchana, P. Upton, J. Yang, T. Crilley et al., Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue, Human Molecular Genetics, vol.17, issue.20, pp.3180-3190, 2008.
DOI : 10.1093/hmg/ddn214

B. Winer, D. Brow, and K. Michels, Statistical Principles in Experimental Design, pp.220-283, 1991.
DOI : 10.1037/11774-000

C. Atkinson, S. Stewart, P. Upton, R. Machado, J. Thomson et al., Primary Pulmonary Hypertension Is Associated With Reduced Pulmonary Vascular Expression of Type II Bone Morphogenetic Protein Receptor, Circulation, vol.105, issue.14, pp.1672-1678, 2002.
DOI : 10.1161/01.CIR.0000012754.72951.3D

P. Upton, L. Long, R. Trembath, and N. Morrell, Functional characterization of bone morphogenetic protein binding sites and Smad1

B. Rondelet, F. Kerbaul, R. Van-beneden, S. Motte, P. Fesler et al., Signaling Molecules in Overcirculation-Induced Pulmonary Hypertension in Piglets: Effects of Sildenafil Therapy, Circulation, vol.110, issue.15, pp.2220-2225, 2004.
DOI : 10.1161/01.CIR.0000143836.40431.F5

R. Morty, B. Nejman, G. Kwapiszewska, M. Hecker, A. Zakrzewicz et al., Dysregulated Bone Morphogenetic Protein Signaling in Monocrotaline-Induced Pulmonary Arterial Hypertension, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.27, issue.5, pp.1072-1078, 2007.
DOI : 10.1161/ATVBAHA.107.141200

M. Mcmurtry, R. Moudgil, and K. Hashimoto, Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension, AJP: Lung Cellular and Molecular Physiology, vol.292, issue.4, pp.872-878, 2006.
DOI : 10.1152/ajplung.00309.2006

M. Takeda, F. Otsuka, K. Nakamura, K. Inagaki, J. Suzuki et al., Characterization of the Bone Morphogenetic Protein (BMP) System in Human Pulmonary Arterial Smooth Muscle Cells Isolated from a Sporadic Case of Primary Pulmonary Hypertension: Roles of BMP Type IB Receptor (Activin Receptor-Like Kinase-6) in the Mitotic Action, Endocrinology, vol.145, issue.9, pp.4344-4354, 2004.
DOI : 10.1210/en.2004-0234

R. Koehler, E. Grunig, M. Pauciulo, M. Hoeper, H. Olschewski et al., Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension, Journal of Medical Genetics, vol.41, issue.12, p.127, 2004.
DOI : 10.1136/jmg.2004.023101

R. Machado, M. Pauciulo, J. Thomson, K. Lane, N. Morgan et al., BMPR2 Haploinsufficiency as the Inherited Molecular Mechanism for Primary Pulmonary Hypertension, The American Journal of Human Genetics, vol.68, issue.1, pp.92-102, 2001.
DOI : 10.1086/316947

N. Rudarakanchana, J. Flanagan, H. Chen, P. Upton, R. Machado et al., Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension, Human Molecular Genetics, vol.11, issue.13, pp.1517-1525, 2002.
DOI : 10.1093/hmg/11.13.1517

X. Yang, L. Long, M. Southwood, N. Rudarakanchana, P. Upton et al., Dysfunctional Smad Signaling Contributes to Abnormal Smooth Muscle Cell Proliferation in Familial Pulmonary Arterial Hypertension, Circulation Research, vol.96, issue.10
DOI : 10.1161/01.RES.0000166926.54293.68

J. Yang, R. Davies, M. Southwood, L. Long, X. Yang et al., Mutations in Bone Morphogenetic Protein Type II Receptor Cause Dysregulation of Id Gene Expression in Pulmonary Artery Smooth Muscle Cells: Implications for Familial Pulmonary Arterial Hypertension, Circulation Research, vol.102, issue.10, pp.1212-1221, 2008.
DOI : 10.1161/CIRCRESAHA.108.173567